PlainRecalls
FDA Drug Moderate Class II Terminated

methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10

Reported: October 25, 2017 Initiated: September 25, 2017 #D-0012-2018

Product Description

methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10

Reason for Recall

Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.

Details

Recalling Firm
RXQ Compounding LLC
Units Affected
945 vials
Distribution
TX, LA, PA, MA, FL, and OH
Location
Athens, OH

Frequently Asked Questions

What product was recalled?
methylPREDNIsolone ACETATE, 40 MG/ML INJECTION SUSPENSION, 10 ML Vial, RXQ Compounding, Athens, OH --- NDC: 70731-0936-10. Recalled by RXQ Compounding LLC. Units affected: 945 vials.
Why was this product recalled?
Lack of Assurance of Sterility; autoclave parameters were not correct for one of two autoclaves used to sterilize the product.
Which agency issued this recall?
This recall was issued by the FDA Drug on October 25, 2017. Severity: Moderate. Recall number: D-0012-2018.